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Background
With the majority of HIV infections resulting from muco-
sal transmission of HIV, induction of an effective mucosal
immune response would be pivotal in preventing trans-
mission. HIV-specific IgA but not IgG has been detected
in genital tract, seminal fluid, urethral swabs, urine and
vaginal wash samples of HIV-negative sex workers and
HIV-status discordant couples. Although present at low
levels, purified mucosal and plasma IgA from HEPS indivi-
duals demonstrated cross-clade neutralizing activity and
were able to inhibit HIV mucosal transcytosis.
Methods
The monoclonal antibody F425-A1g8 was generated in
our laboratory by hybridoma technique and showed bind-
ing activity to the CD4i site of gp120. We isolated the vari-
able genes of heavy chain (VH) and light chain (VL) from
the hybridoma cell line and cloned the VH fragment into
the vectors pHC-HuCg1 and pHC-huCa1 individually, as
well as cloned VL into the vector pLC-huCk. Both of VH
and VL plasmids were co-transfected into CHO-K1 cells
in equimolar amounts and established F425-A1g8 IgG1
and IgA1 expressing cell lines. We characterized the
impact of different isotype variants of F425-A1g8 to HIV
neutralizing activity by direct HIV viral neutralizing assay
and antibody dependent cell-mediated viral inhibition.
Results
The switching constant domain of F425-A1g8 to con-
struct IgG1 and IgA1 isotypes do not impact their bind-
ing activity with the CD4 site binding site of HIV. The
result of neutralization showed that in contrast to little
neutralization by F425-A1 g 8I g G 1i nt h ea b s e n c eo f
sCD4, the IgA1 variant of the antibody displayed signifi-
cant neutralization activity against a range of HIV clade
B isolates.
Conclusion
This research clearly suggests that IgA isotype utilizing its
unique molecular structure plays an important role in
HIV neutralization. The studies of the neutralizing func-
tion of IgA isotypes may also serve to inform the design of
vaccine strategies that may be more effective at preventing
mucosal transmission.
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